Literature DB >> 10638553

Gender role and irritable bowel syndrome: literature review and hypothesis.

B B Toner1, D Akman.   

Abstract

Studies examining the prevalence of irritable bowel syndrome (IBS) consistently show that women outnumber men in both patient and nonpatient populations. However, because IBS does affect both women and men, it is important to examine and to understand gender similarities and differences in the expression of this complex disorder. Studies that have explored gender differences have focused their investigations on prevalence and health seeking behavior, physical and psychological symptomotology, and abuse history. This article reviews and summarizes the findings from those studies. As well, whereas the literature examining differences between men and women with IBS has focused on distinctions based on the biological sex of study participants, this article offers an alternate approach to the exploration of gender differences. The concept of gender role, defined as generalizations about appropriate male and female traits that are associated with masculinity and femininity, may further our understanding of IBS in both women and men.

Entities:  

Mesh:

Year:  2000        PMID: 10638553     DOI: 10.1111/j.1572-0241.2000.01698.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  25 in total

Review 1.  [Functional somatic pain syndromes: summary of hypotheses of their overlap and etiology].

Authors:  P Henningsen; C Derra; J C Türp; W Häuser
Journal:  Schmerz       Date:  2004-04       Impact factor: 1.107

Review 2.  New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.

Authors:  Emanuele Sinagra; Gaetano Cristian Morreale; Ghazaleh Mohammadian; Giorgio Fusco; Valentina Guarnotta; Giovanni Tomasello; Francesco Cappello; Francesca Rossi; Georgios Amvrosiadis; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

Review 3.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

4.  Estrogen modulation of visceral nociceptors.

Authors:  Victor Chaban
Journal:  Curr Trends Neurol       Date:  2013

5.  Pain hypersensitivity in patients with functional gastrointestinal disorders: a gastrointestinal-specific defect or a general systemic condition?

Authors:  M Bouin; P Meunier; M Riberdy-Poitras; P Poitras
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

Review 6.  The role of gender and biological sex in irritable bowel syndrome.

Authors:  Christine L Frissora; Kenneth L Koch
Journal:  Curr Gastroenterol Rep       Date:  2005-08

7.  Iron deficiency suppresses ileal nitric oxide synthase activity.

Authors:  M I Goldblatt; S H Choi; D A Swartz-Basile; A Nakeeb; S K Sarna; H A Pitt
Journal:  J Gastrointest Surg       Date:  2001 Jul-Aug       Impact factor: 3.452

8.  Irritable bowel syndrome is more common in women regardless of the menstrual phase: a Rome II-based survey.

Authors:  Sun-Young Lee; Jeong Hwan Kim; In-Kyung Sung; Hyung Seok Park; Choon-Jo Jin; Won Hyeok Choe; So Young Kwon; Chang Hong Lee; Kyoo Wan Choi
Journal:  J Korean Med Sci       Date:  2007-10       Impact factor: 2.153

9.  Sex differences in the activation of the spinoparabrachial circuit by visceral pain.

Authors:  Anne Z Murphy; Shelby K Suckow; Malcolm Johns; Richard J Traub
Journal:  Physiol Behav       Date:  2009-03-09

10.  Is female predominance in irritable bowel syndrome related to fibromyalgia?

Authors:  Selami Akkuş; Altug Senol; Naime Bayram Ayvacioglu; Ercan Tunc; Ibrahim Eren; Mehmet Isler
Journal:  Rheumatol Int       Date:  2003-07-16       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.